Global Sickle Cell Anemia Therapeutics Market Growth (Status and Outlook) 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Sickle Cell Anemia Therapeutics market size is predicted to grow from US$ 4369 million in 2025 to US$ 10800 million in 2031; it is expected to grow at a CAGR of 16.3% from 2025 to 2031.
Sickle cell disease (SCD) is a chronic, inherited blood disorder that impacts hemoglobin, a protein found in red blood cells (RBCs) that carries oxygen throughout the body. The disease is caused by a genetic mutation in the beta-chain of hemoglobin, which results in the formation of abnormal hemoglobin known as sickle hemoglobin (HbS).
Global Sickle Cell Anemia Therapeutics key players include Emmaus Medical, Addmedica, Gamida Cell, GlycoMimetics, etc.
Americas is the largest market, with a share about 55%, followed by Europe, and Middle East & Africa, both have a share over 35 percent.
In terms of product, Blood Transfusion is the largest segment, with a share over 35%. And in terms of application, the largest application is Child, followed by Adult.
LPI (LP Information)' newest research report, the “Sickle Cell Anemia Therapeutics Industry Forecast” looks at past sales and reviews total world Sickle Cell Anemia Therapeutics sales in 2024, providing a comprehensive analysis by region and market sector of projected Sickle Cell Anemia Therapeutics sales for 2025 through 2031. With Sickle Cell Anemia Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Sickle Cell Anemia Therapeutics industry.
This Insight Report provides a comprehensive analysis of the global Sickle Cell Anemia Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Sickle Cell Anemia Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Sickle Cell Anemia Therapeutics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Sickle Cell Anemia Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Sickle Cell Anemia Therapeutics.
This report presents a comprehensive overview, market shares, and growth opportunities of Sickle Cell Anemia Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by Type:
The global Sickle Cell Anemia Therapeutics market size is predicted to grow from US$ 4369 million in 2025 to US$ 10800 million in 2031; it is expected to grow at a CAGR of 16.3% from 2025 to 2031.
Sickle cell disease (SCD) is a chronic, inherited blood disorder that impacts hemoglobin, a protein found in red blood cells (RBCs) that carries oxygen throughout the body. The disease is caused by a genetic mutation in the beta-chain of hemoglobin, which results in the formation of abnormal hemoglobin known as sickle hemoglobin (HbS).
Global Sickle Cell Anemia Therapeutics key players include Emmaus Medical, Addmedica, Gamida Cell, GlycoMimetics, etc.
Americas is the largest market, with a share about 55%, followed by Europe, and Middle East & Africa, both have a share over 35 percent.
In terms of product, Blood Transfusion is the largest segment, with a share over 35%. And in terms of application, the largest application is Child, followed by Adult.
LPI (LP Information)' newest research report, the “Sickle Cell Anemia Therapeutics Industry Forecast” looks at past sales and reviews total world Sickle Cell Anemia Therapeutics sales in 2024, providing a comprehensive analysis by region and market sector of projected Sickle Cell Anemia Therapeutics sales for 2025 through 2031. With Sickle Cell Anemia Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Sickle Cell Anemia Therapeutics industry.
This Insight Report provides a comprehensive analysis of the global Sickle Cell Anemia Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Sickle Cell Anemia Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Sickle Cell Anemia Therapeutics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Sickle Cell Anemia Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Sickle Cell Anemia Therapeutics.
This report presents a comprehensive overview, market shares, and growth opportunities of Sickle Cell Anemia Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Blood Transfusion
- Pharmacotherapy
- Bone Marrow Transplant
- Child
- Adult
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Emmaus Medical
- Addmedica
- Gamida Cell
- GlycoMimetics
- Pfizer
- Novartis
- Global Blood Therapeutics
- Micelle BioPharma
- Bluebird Bio
- Prolong Pharmaceuticals
- Modus Therapeutics
- Sangamo Biosciences
- Bioverativ
- Imara
- Ironwood Pharmaceuticals
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Sickle Cell Anemia Therapeutics Market Size (2020-2031)
2.1.2 Sickle Cell Anemia Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Sickle Cell Anemia Therapeutics by Country/Region (2020, 2024 & 2031)
2.2 Sickle Cell Anemia Therapeutics Segment by Type
2.2.1 Blood Transfusion
2.2.2 Pharmacotherapy
2.2.3 Bone Marrow Transplant
2.3 Sickle Cell Anemia Therapeutics Market Size by Type
2.3.1 Sickle Cell Anemia Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Sickle Cell Anemia Therapeutics Market Size Market Share by Type (2020-2025)
2.4 Sickle Cell Anemia Therapeutics Segment by Application
2.4.1 Child
2.4.2 Adult
2.5 Sickle Cell Anemia Therapeutics Market Size by Application
2.5.1 Sickle Cell Anemia Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Sickle Cell Anemia Therapeutics Market Size Market Share by Application (2020-2025)
3 SICKLE CELL ANEMIA THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Sickle Cell Anemia Therapeutics Market Size Market Share by Player
3.1.1 Global Sickle Cell Anemia Therapeutics Revenue by Player (2020-2025)
3.1.2 Global Sickle Cell Anemia Therapeutics Revenue Market Share by Player (2020-2025)
3.2 Global Sickle Cell Anemia Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 SICKLE CELL ANEMIA THERAPEUTICS BY REGION
4.1 Sickle Cell Anemia Therapeutics Market Size by Region (2020-2025)
4.2 Global Sickle Cell Anemia Therapeutics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Sickle Cell Anemia Therapeutics Market Size Growth (2020-2025)
4.4 APAC Sickle Cell Anemia Therapeutics Market Size Growth (2020-2025)
4.5 Europe Sickle Cell Anemia Therapeutics Market Size Growth (2020-2025)
4.6 Middle East & Africa Sickle Cell Anemia Therapeutics Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Sickle Cell Anemia Therapeutics Market Size by Country (2020-2025)
5.2 Americas Sickle Cell Anemia Therapeutics Market Size by Type (2020-2025)
5.3 Americas Sickle Cell Anemia Therapeutics Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Sickle Cell Anemia Therapeutics Market Size by Region (2020-2025)
6.2 APAC Sickle Cell Anemia Therapeutics Market Size by Type (2020-2025)
6.3 APAC Sickle Cell Anemia Therapeutics Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Sickle Cell Anemia Therapeutics Market Size by Country (2020-2025)
7.2 Europe Sickle Cell Anemia Therapeutics Market Size by Type (2020-2025)
7.3 Europe Sickle Cell Anemia Therapeutics Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Sickle Cell Anemia Therapeutics by Region (2020-2025)
8.2 Middle East & Africa Sickle Cell Anemia Therapeutics Market Size by Type (2020-2025)
8.3 Middle East & Africa Sickle Cell Anemia Therapeutics Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL SICKLE CELL ANEMIA THERAPEUTICS MARKET FORECAST
10.1 Global Sickle Cell Anemia Therapeutics Forecast by Region (2026-2031)
10.1.1 Global Sickle Cell Anemia Therapeutics Forecast by Region (2026-2031)
10.1.2 Americas Sickle Cell Anemia Therapeutics Forecast
10.1.3 APAC Sickle Cell Anemia Therapeutics Forecast
10.1.4 Europe Sickle Cell Anemia Therapeutics Forecast
10.1.5 Middle East & Africa Sickle Cell Anemia Therapeutics Forecast
10.2 Americas Sickle Cell Anemia Therapeutics Forecast by Country (2026-2031)
10.2.1 United States Market Sickle Cell Anemia Therapeutics Forecast
10.2.2 Canada Market Sickle Cell Anemia Therapeutics Forecast
10.2.3 Mexico Market Sickle Cell Anemia Therapeutics Forecast
10.2.4 Brazil Market Sickle Cell Anemia Therapeutics Forecast
10.3 APAC Sickle Cell Anemia Therapeutics Forecast by Region (2026-2031)
10.3.1 China Sickle Cell Anemia Therapeutics Market Forecast
10.3.2 Japan Market Sickle Cell Anemia Therapeutics Forecast
10.3.3 Korea Market Sickle Cell Anemia Therapeutics Forecast
10.3.4 Southeast Asia Market Sickle Cell Anemia Therapeutics Forecast
10.3.5 India Market Sickle Cell Anemia Therapeutics Forecast
10.3.6 Australia Market Sickle Cell Anemia Therapeutics Forecast
10.4 Europe Sickle Cell Anemia Therapeutics Forecast by Country (2026-2031)
10.4.1 Germany Market Sickle Cell Anemia Therapeutics Forecast
10.4.2 France Market Sickle Cell Anemia Therapeutics Forecast
10.4.3 UK Market Sickle Cell Anemia Therapeutics Forecast
10.4.4 Italy Market Sickle Cell Anemia Therapeutics Forecast
10.4.5 Russia Market Sickle Cell Anemia Therapeutics Forecast
10.5 Middle East & Africa Sickle Cell Anemia Therapeutics Forecast by Region (2026-2031)
10.5.1 Egypt Market Sickle Cell Anemia Therapeutics Forecast
10.5.2 South Africa Market Sickle Cell Anemia Therapeutics Forecast
10.5.3 Israel Market Sickle Cell Anemia Therapeutics Forecast
10.5.4 Turkey Market Sickle Cell Anemia Therapeutics Forecast
10.6 Global Sickle Cell Anemia Therapeutics Forecast by Type (2026-2031)
10.7 Global Sickle Cell Anemia Therapeutics Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Sickle Cell Anemia Therapeutics Forecast
11 KEY PLAYERS ANALYSIS
11.1 Emmaus Medical
11.1.1 Emmaus Medical Company Information
11.1.2 Emmaus Medical Sickle Cell Anemia Therapeutics Product Offered
11.1.3 Emmaus Medical Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Emmaus Medical Main Business Overview
11.1.5 Emmaus Medical Latest Developments
11.2 Addmedica
11.2.1 Addmedica Company Information
11.2.2 Addmedica Sickle Cell Anemia Therapeutics Product Offered
11.2.3 Addmedica Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Addmedica Main Business Overview
11.2.5 Addmedica Latest Developments
11.3 Gamida Cell
11.3.1 Gamida Cell Company Information
11.3.2 Gamida Cell Sickle Cell Anemia Therapeutics Product Offered
11.3.3 Gamida Cell Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Gamida Cell Main Business Overview
11.3.5 Gamida Cell Latest Developments
11.4 GlycoMimetics
11.4.1 GlycoMimetics Company Information
11.4.2 GlycoMimetics Sickle Cell Anemia Therapeutics Product Offered
11.4.3 GlycoMimetics Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 GlycoMimetics Main Business Overview
11.4.5 GlycoMimetics Latest Developments
11.5 Pfizer
11.5.1 Pfizer Company Information
11.5.2 Pfizer Sickle Cell Anemia Therapeutics Product Offered
11.5.3 Pfizer Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Pfizer Main Business Overview
11.5.5 Pfizer Latest Developments
11.6 Novartis
11.6.1 Novartis Company Information
11.6.2 Novartis Sickle Cell Anemia Therapeutics Product Offered
11.6.3 Novartis Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Novartis Main Business Overview
11.6.5 Novartis Latest Developments
11.7 Global Blood Therapeutics
11.7.1 Global Blood Therapeutics Company Information
11.7.2 Global Blood Therapeutics Sickle Cell Anemia Therapeutics Product Offered
11.7.3 Global Blood Therapeutics Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Global Blood Therapeutics Main Business Overview
11.7.5 Global Blood Therapeutics Latest Developments
11.8 Micelle BioPharma
11.8.1 Micelle BioPharma Company Information
11.8.2 Micelle BioPharma Sickle Cell Anemia Therapeutics Product Offered
11.8.3 Micelle BioPharma Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Micelle BioPharma Main Business Overview
11.8.5 Micelle BioPharma Latest Developments
11.9 Bluebird Bio
11.9.1 Bluebird Bio Company Information
11.9.2 Bluebird Bio Sickle Cell Anemia Therapeutics Product Offered
11.9.3 Bluebird Bio Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Bluebird Bio Main Business Overview
11.9.5 Bluebird Bio Latest Developments
11.10 Prolong Pharmaceuticals
11.10.1 Prolong Pharmaceuticals Company Information
11.10.2 Prolong Pharmaceuticals Sickle Cell Anemia Therapeutics Product Offered
11.10.3 Prolong Pharmaceuticals Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Prolong Pharmaceuticals Main Business Overview
11.10.5 Prolong Pharmaceuticals Latest Developments
11.11 Modus Therapeutics
11.11.1 Modus Therapeutics Company Information
11.11.2 Modus Therapeutics Sickle Cell Anemia Therapeutics Product Offered
11.11.3 Modus Therapeutics Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Modus Therapeutics Main Business Overview
11.11.5 Modus Therapeutics Latest Developments
11.12 Sangamo Biosciences
11.12.1 Sangamo Biosciences Company Information
11.12.2 Sangamo Biosciences Sickle Cell Anemia Therapeutics Product Offered
11.12.3 Sangamo Biosciences Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Sangamo Biosciences Main Business Overview
11.12.5 Sangamo Biosciences Latest Developments
11.13 Bioverativ
11.13.1 Bioverativ Company Information
11.13.2 Bioverativ Sickle Cell Anemia Therapeutics Product Offered
11.13.3 Bioverativ Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Bioverativ Main Business Overview
11.13.5 Bioverativ Latest Developments
11.14 Imara
11.14.1 Imara Company Information
11.14.2 Imara Sickle Cell Anemia Therapeutics Product Offered
11.14.3 Imara Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Imara Main Business Overview
11.14.5 Imara Latest Developments
11.15 Ironwood Pharmaceuticals
11.15.1 Ironwood Pharmaceuticals Company Information
11.15.2 Ironwood Pharmaceuticals Sickle Cell Anemia Therapeutics Product Offered
11.15.3 Ironwood Pharmaceuticals Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Ironwood Pharmaceuticals Main Business Overview
11.15.5 Ironwood Pharmaceuticals Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Sickle Cell AnemiaTherapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Sickle Cell AnemiaTherapeutics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of BloodTransfusion
Table 4. Major Players of Pharmacotherapy
Table 5. Major Players of Bone MarrowTransplant
Table 6. Sickle Cell AnemiaTherapeutics Market Size CAGR byType (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Sickle Cell AnemiaTherapeutics Market Size byType (2020-2025) & ($ millions)
Table 8. Global Sickle Cell AnemiaTherapeutics Market Size Market Share byType (2020-2025)
Table 9. Sickle Cell AnemiaTherapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Sickle Cell AnemiaTherapeutics Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Sickle Cell AnemiaTherapeutics Market Size Market Share by Application (2020-2025)
Table 12. Global Sickle Cell AnemiaTherapeutics Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Sickle Cell AnemiaTherapeutics Revenue Market Share by Player (2020-2025)
Table 14. Sickle Cell AnemiaTherapeutics Key Players Head office and Products Offered
Table 15. Sickle Cell AnemiaTherapeutics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Sickle Cell AnemiaTherapeutics Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Sickle Cell AnemiaTherapeutics Market Size Market Share by Region (2020-2025)
Table 20. Global Sickle Cell AnemiaTherapeutics Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Sickle Cell AnemiaTherapeutics Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Sickle Cell AnemiaTherapeutics Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Sickle Cell AnemiaTherapeutics Market Size Market Share by Country (2020-2025)
Table 24. Americas Sickle Cell AnemiaTherapeutics Market Size byType (2020-2025) & ($ millions)
Table 25. Americas Sickle Cell AnemiaTherapeutics Market Size Market Share byType (2020-2025)
Table 26. Americas Sickle Cell AnemiaTherapeutics Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Sickle Cell AnemiaTherapeutics Market Size Market Share by Application (2020-2025)
Table 28. APAC Sickle Cell AnemiaTherapeutics Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Sickle Cell AnemiaTherapeutics Market Size Market Share by Region (2020-2025)
Table 30. APAC Sickle Cell AnemiaTherapeutics Market Size byType (2020-2025) & ($ millions)
Table 31. APAC Sickle Cell AnemiaTherapeutics Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Sickle Cell AnemiaTherapeutics Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Sickle Cell AnemiaTherapeutics Market Size Market Share by Country (2020-2025)
Table 34. Europe Sickle Cell AnemiaTherapeutics Market Size byType (2020-2025) & ($ millions)
Table 35. Europe Sickle Cell AnemiaTherapeutics Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Sickle Cell AnemiaTherapeutics Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Sickle Cell AnemiaTherapeutics Market Size byType (2020-2025) & ($ millions)
Table 38. Middle East & Africa Sickle Cell AnemiaTherapeutics Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Sickle Cell AnemiaTherapeutics
Table 40. Key Market Challenges & Risks of Sickle Cell AnemiaTherapeutics
Table 41. Key IndustryTrends of Sickle Cell AnemiaTherapeutics
Table 42. Global Sickle Cell AnemiaTherapeutics Market SizeForecast by Region (2026-2031) & ($ millions)
Table 43. Global Sickle Cell AnemiaTherapeutics Market Size Market ShareForecast by Region (2026-2031)
Table 44. Global Sickle Cell AnemiaTherapeutics Market SizeForecast byType (2026-2031) & ($ millions)
Table 45. Global Sickle Cell AnemiaTherapeutics Market SizeForecast by Application (2026-2031) & ($ millions)
Table 46. Emmaus Medical Details, CompanyType, Sickle Cell AnemiaTherapeutics Area Served and Its Competitors
Table 47. Emmaus Medical Sickle Cell AnemiaTherapeutics Product Offered
Table 48. Emmaus Medical Sickle Cell AnemiaTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Emmaus Medical Main Business
Table 50. Emmaus Medical Latest Developments
Table 51. Addmedica Details, CompanyType, Sickle Cell AnemiaTherapeutics Area Served and Its Competitors
Table 52. Addmedica Sickle Cell AnemiaTherapeutics Product Offered
Table 53. Addmedica Sickle Cell AnemiaTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Addmedica Main Business
Table 55. Addmedica Latest Developments
Table 56. Gamida Cell Details, CompanyType, Sickle Cell AnemiaTherapeutics Area Served and Its Competitors
Table 57. Gamida Cell Sickle Cell AnemiaTherapeutics Product Offered
Table 58. Gamida Cell Sickle Cell AnemiaTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Gamida Cell Main Business
Table 60. Gamida Cell Latest Developments
Table 61. GlycoMimetics Details, CompanyType, Sickle Cell AnemiaTherapeutics Area Served and Its Competitors
Table 62. GlycoMimetics Sickle Cell AnemiaTherapeutics Product Offered
Table 63. GlycoMimetics Sickle Cell AnemiaTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. GlycoMimetics Main Business
Table 65. GlycoMimetics Latest Developments
Table 66. Pfizer Details, CompanyType, Sickle Cell AnemiaTherapeutics Area Served and Its Competitors
Table 67. Pfizer Sickle Cell AnemiaTherapeutics Product Offered
Table 68. Pfizer Sickle Cell AnemiaTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. Pfizer Main Business
Table 70. Pfizer Latest Developments
Table 71. Novartis Details, CompanyType, Sickle Cell AnemiaTherapeutics Area Served and Its Competitors
Table 72. Novartis Sickle Cell AnemiaTherapeutics Product Offered
Table 73. Novartis Sickle Cell AnemiaTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Novartis Main Business
Table 75. Novartis Latest Developments
Table 76. Global BloodTherapeutics Details, CompanyType, Sickle Cell AnemiaTherapeutics Area Served and Its Competitors
Table 77. Global BloodTherapeutics Sickle Cell AnemiaTherapeutics Product Offered
Table 78. Global BloodTherapeutics Sickle Cell AnemiaTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. Global BloodTherapeutics Main Business
Table 80. Global BloodTherapeutics Latest Developments
Table 81. Micelle BioPharma Details, CompanyType, Sickle Cell AnemiaTherapeutics Area Served and Its Competitors
Table 82. Micelle BioPharma Sickle Cell AnemiaTherapeutics Product Offered
Table 83. Micelle BioPharma Sickle Cell AnemiaTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. Micelle BioPharma Main Business
Table 85. Micelle BioPharma Latest Developments
Table 86. Bluebird Bio Details, CompanyType, Sickle Cell AnemiaTherapeutics Area Served and Its Competitors
Table 87. Bluebird Bio Sickle Cell AnemiaTherapeutics Product Offered
Table 88. Bluebird Bio Sickle Cell AnemiaTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. Bluebird Bio Main Business
Table 90. Bluebird Bio Latest Developments
Table 91. Prolong Pharmaceuticals Details, CompanyType, Sickle Cell AnemiaTherapeutics Area Served and Its Competitors
Table 92. Prolong Pharmaceuticals Sickle Cell AnemiaTherapeutics Product Offered
Table 93. Prolong Pharmaceuticals Sickle Cell AnemiaTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 94. Prolong Pharmaceuticals Main Business
Table 95. Prolong Pharmaceuticals Latest Developments
Table 96. ModusTherapeutics Details, CompanyType, Sickle Cell AnemiaTherapeutics Area Served and Its Competitors
Table 97. ModusTherapeutics Sickle Cell AnemiaTherapeutics Product Offered
Table 98. ModusTherapeutics Sickle Cell AnemiaTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 99. ModusTherapeutics Main Business
Table 100. ModusTherapeutics Latest Developments
Table 101. Sangamo Biosciences Details, CompanyType, Sickle Cell AnemiaTherapeutics Area Served and Its Competitors
Table 102. Sangamo Biosciences Sickle Cell AnemiaTherapeutics Product Offered
Table 103. Sangamo Biosciences Sickle Cell AnemiaTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 104. Sangamo Biosciences Main Business
Table 105. Sangamo Biosciences Latest Developments
Table 106. Bioverativ Details, CompanyType, Sickle Cell AnemiaTherapeutics Area Served and Its Competitors
Table 107. Bioverativ Sickle Cell AnemiaTherapeutics Product Offered
Table 108. Bioverativ Sickle Cell AnemiaTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 109. Bioverativ Main Business
Table 110. Bioverativ Latest Developments
Table 111. Imara Details, CompanyType, Sickle Cell AnemiaTherapeutics Area Served and Its Competitors
Table 112. Imara Sickle Cell AnemiaTherapeutics Product Offered
Table 113. Imara Sickle Cell AnemiaTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 114. Imara Main Business
Table 115. Imara Latest Developments
Table 116. Ironwood Pharmaceuticals Details, CompanyType, Sickle Cell AnemiaTherapeutics Area Served and Its Competitors
Table 117. Ironwood Pharmaceuticals Sickle Cell AnemiaTherapeutics Product Offered
Table 118. Ironwood Pharmaceuticals Sickle Cell AnemiaTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 119. Ironwood Pharmaceuticals Main Business
Table 120. Ironwood Pharmaceuticals Latest Developments
LIST OFFIGURES
Figure 1. Sickle Cell AnemiaTherapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Sickle Cell AnemiaTherapeutics Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Sickle Cell AnemiaTherapeutics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Sickle Cell AnemiaTherapeutics Sales Market Share by Country/Region (2024)
Figure 8. Sickle Cell AnemiaTherapeutics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Sickle Cell AnemiaTherapeutics Market Size Market Share byType in 2024
Figure 10. Sickle Cell AnemiaTherapeutics in Child
Figure 11. Global Sickle Cell AnemiaTherapeutics Market: Child (2020-2025) & ($ millions)
Figure 12. Sickle Cell AnemiaTherapeutics in Adult
Figure 13. Global Sickle Cell AnemiaTherapeutics Market: Adult (2020-2025) & ($ millions)
Figure 14. Global Sickle Cell AnemiaTherapeutics Market Size Market Share by Application in 2024
Figure 15. Global Sickle Cell AnemiaTherapeutics Revenue Market Share by Player in 2024
Figure 16. Global Sickle Cell AnemiaTherapeutics Market Size Market Share by Region (2020-2025)
Figure 17. Americas Sickle Cell AnemiaTherapeutics Market Size 2020-2025 ($ millions)
Figure 18. APAC Sickle Cell AnemiaTherapeutics Market Size 2020-2025 ($ millions)
Figure 19. Europe Sickle Cell AnemiaTherapeutics Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa Sickle Cell AnemiaTherapeutics Market Size 2020-2025 ($ millions)
Figure 21. Americas Sickle Cell AnemiaTherapeutics Value Market Share by Country in 2024
Figure 22. United States Sickle Cell AnemiaTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada Sickle Cell AnemiaTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico Sickle Cell AnemiaTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil Sickle Cell AnemiaTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC Sickle Cell AnemiaTherapeutics Market Size Market Share by Region in 2024
Figure 27. APAC Sickle Cell AnemiaTherapeutics Market Size Market Share byType (2020-2025)
Figure 28. APAC Sickle Cell AnemiaTherapeutics Market Size Market Share by Application (2020-2025)
Figure 29. China Sickle Cell AnemiaTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan Sickle Cell AnemiaTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea Sickle Cell AnemiaTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia Sickle Cell AnemiaTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 33. India Sickle Cell AnemiaTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia Sickle Cell AnemiaTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe Sickle Cell AnemiaTherapeutics Market Size Market Share by Country in 2024
Figure 36. Europe Sickle Cell AnemiaTherapeutics Market Size Market Share byType (2020-2025)
Figure 37. Europe Sickle Cell AnemiaTherapeutics Market Size Market Share by Application (2020-2025)
Figure 38. Germany Sickle Cell AnemiaTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 39.France Sickle Cell AnemiaTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 40. UK Sickle Cell AnemiaTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy Sickle Cell AnemiaTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia Sickle Cell AnemiaTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa Sickle Cell AnemiaTherapeutics Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa Sickle Cell AnemiaTherapeutics Market Size Market Share byType (2020-2025)
Figure 45. Middle East & Africa Sickle Cell AnemiaTherapeutics Market Size Market Share by Application (2020-2025)
Figure 46. Egypt Sickle Cell AnemiaTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa Sickle Cell AnemiaTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel Sickle Cell AnemiaTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 49.Turkey Sickle Cell AnemiaTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries Sickle Cell AnemiaTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas Sickle Cell AnemiaTherapeutics Market Size 2026-2031 ($ millions)
Figure 52. APAC Sickle Cell AnemiaTherapeutics Market Size 2026-2031 ($ millions)
Figure 53. Europe Sickle Cell AnemiaTherapeutics Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa Sickle Cell AnemiaTherapeutics Market Size 2026-2031 ($ millions)
Figure 55. United States Sickle Cell AnemiaTherapeutics Market Size 2026-2031 ($ millions)
Figure 56. Canada Sickle Cell AnemiaTherapeutics Market Size 2026-2031 ($ millions)
Figure 57. Mexico Sickle Cell AnemiaTherapeutics Market Size 2026-2031 ($ millions)
Figure 58. Brazil Sickle Cell AnemiaTherapeutics Market Size 2026-2031 ($ millions)
Figure 59. China Sickle Cell AnemiaTherapeutics Market Size 2026-2031 ($ millions)
Figure 60. Japan Sickle Cell AnemiaTherapeutics Market Size 2026-2031 ($ millions)
Figure 61. Korea Sickle Cell AnemiaTherapeutics Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia Sickle Cell AnemiaTherapeutics Market Size 2026-2031 ($ millions)
Figure 63. India Sickle Cell AnemiaTherapeutics Market Size 2026-2031 ($ millions)
Figure 64. Australia Sickle Cell AnemiaTherapeutics Market Size 2026-2031 ($ millions)
Figure 65. Germany Sickle Cell AnemiaTherapeutics Market Size 2026-2031 ($ millions)
Figure 66.France Sickle Cell AnemiaTherapeutics Market Size 2026-2031 ($ millions)
Figure 67. UK Sickle Cell AnemiaTherapeutics Market Size 2026-2031 ($ millions)
Figure 68. Italy Sickle Cell AnemiaTherapeutics Market Size 2026-2031 ($ millions)
Figure 69. Russia Sickle Cell AnemiaTherapeutics Market Size 2026-2031 ($ millions)
Figure 70. Egypt Sickle Cell AnemiaTherapeutics Market Size 2026-2031 ($ millions)
Figure 71. South Africa Sickle Cell AnemiaTherapeutics Market Size 2026-2031 ($ millions)
Figure 72. Israel Sickle Cell AnemiaTherapeutics Market Size 2026-2031 ($ millions)
Figure 73.Turkey Sickle Cell AnemiaTherapeutics Market Size 2026-2031 ($ millions)
Figure 74. Global Sickle Cell AnemiaTherapeutics Market Size Market ShareForecast byType (2026-2031)
Figure 75. Global Sickle Cell AnemiaTherapeutics Market Size Market ShareForecast by Application (2026-2031)
Figure 76. GCC Countries Sickle Cell AnemiaTherapeutics Market Size 2026-2031 ($ millions)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Sickle Cell Anemia Therapeutics Market Size (2020-2031)
2.1.2 Sickle Cell Anemia Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Sickle Cell Anemia Therapeutics by Country/Region (2020, 2024 & 2031)
2.2 Sickle Cell Anemia Therapeutics Segment by Type
2.2.1 Blood Transfusion
2.2.2 Pharmacotherapy
2.2.3 Bone Marrow Transplant
2.3 Sickle Cell Anemia Therapeutics Market Size by Type
2.3.1 Sickle Cell Anemia Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Sickle Cell Anemia Therapeutics Market Size Market Share by Type (2020-2025)
2.4 Sickle Cell Anemia Therapeutics Segment by Application
2.4.1 Child
2.4.2 Adult
2.5 Sickle Cell Anemia Therapeutics Market Size by Application
2.5.1 Sickle Cell Anemia Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Sickle Cell Anemia Therapeutics Market Size Market Share by Application (2020-2025)
3 SICKLE CELL ANEMIA THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Sickle Cell Anemia Therapeutics Market Size Market Share by Player
3.1.1 Global Sickle Cell Anemia Therapeutics Revenue by Player (2020-2025)
3.1.2 Global Sickle Cell Anemia Therapeutics Revenue Market Share by Player (2020-2025)
3.2 Global Sickle Cell Anemia Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 SICKLE CELL ANEMIA THERAPEUTICS BY REGION
4.1 Sickle Cell Anemia Therapeutics Market Size by Region (2020-2025)
4.2 Global Sickle Cell Anemia Therapeutics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Sickle Cell Anemia Therapeutics Market Size Growth (2020-2025)
4.4 APAC Sickle Cell Anemia Therapeutics Market Size Growth (2020-2025)
4.5 Europe Sickle Cell Anemia Therapeutics Market Size Growth (2020-2025)
4.6 Middle East & Africa Sickle Cell Anemia Therapeutics Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Sickle Cell Anemia Therapeutics Market Size by Country (2020-2025)
5.2 Americas Sickle Cell Anemia Therapeutics Market Size by Type (2020-2025)
5.3 Americas Sickle Cell Anemia Therapeutics Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Sickle Cell Anemia Therapeutics Market Size by Region (2020-2025)
6.2 APAC Sickle Cell Anemia Therapeutics Market Size by Type (2020-2025)
6.3 APAC Sickle Cell Anemia Therapeutics Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Sickle Cell Anemia Therapeutics Market Size by Country (2020-2025)
7.2 Europe Sickle Cell Anemia Therapeutics Market Size by Type (2020-2025)
7.3 Europe Sickle Cell Anemia Therapeutics Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Sickle Cell Anemia Therapeutics by Region (2020-2025)
8.2 Middle East & Africa Sickle Cell Anemia Therapeutics Market Size by Type (2020-2025)
8.3 Middle East & Africa Sickle Cell Anemia Therapeutics Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL SICKLE CELL ANEMIA THERAPEUTICS MARKET FORECAST
10.1 Global Sickle Cell Anemia Therapeutics Forecast by Region (2026-2031)
10.1.1 Global Sickle Cell Anemia Therapeutics Forecast by Region (2026-2031)
10.1.2 Americas Sickle Cell Anemia Therapeutics Forecast
10.1.3 APAC Sickle Cell Anemia Therapeutics Forecast
10.1.4 Europe Sickle Cell Anemia Therapeutics Forecast
10.1.5 Middle East & Africa Sickle Cell Anemia Therapeutics Forecast
10.2 Americas Sickle Cell Anemia Therapeutics Forecast by Country (2026-2031)
10.2.1 United States Market Sickle Cell Anemia Therapeutics Forecast
10.2.2 Canada Market Sickle Cell Anemia Therapeutics Forecast
10.2.3 Mexico Market Sickle Cell Anemia Therapeutics Forecast
10.2.4 Brazil Market Sickle Cell Anemia Therapeutics Forecast
10.3 APAC Sickle Cell Anemia Therapeutics Forecast by Region (2026-2031)
10.3.1 China Sickle Cell Anemia Therapeutics Market Forecast
10.3.2 Japan Market Sickle Cell Anemia Therapeutics Forecast
10.3.3 Korea Market Sickle Cell Anemia Therapeutics Forecast
10.3.4 Southeast Asia Market Sickle Cell Anemia Therapeutics Forecast
10.3.5 India Market Sickle Cell Anemia Therapeutics Forecast
10.3.6 Australia Market Sickle Cell Anemia Therapeutics Forecast
10.4 Europe Sickle Cell Anemia Therapeutics Forecast by Country (2026-2031)
10.4.1 Germany Market Sickle Cell Anemia Therapeutics Forecast
10.4.2 France Market Sickle Cell Anemia Therapeutics Forecast
10.4.3 UK Market Sickle Cell Anemia Therapeutics Forecast
10.4.4 Italy Market Sickle Cell Anemia Therapeutics Forecast
10.4.5 Russia Market Sickle Cell Anemia Therapeutics Forecast
10.5 Middle East & Africa Sickle Cell Anemia Therapeutics Forecast by Region (2026-2031)
10.5.1 Egypt Market Sickle Cell Anemia Therapeutics Forecast
10.5.2 South Africa Market Sickle Cell Anemia Therapeutics Forecast
10.5.3 Israel Market Sickle Cell Anemia Therapeutics Forecast
10.5.4 Turkey Market Sickle Cell Anemia Therapeutics Forecast
10.6 Global Sickle Cell Anemia Therapeutics Forecast by Type (2026-2031)
10.7 Global Sickle Cell Anemia Therapeutics Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Sickle Cell Anemia Therapeutics Forecast
11 KEY PLAYERS ANALYSIS
11.1 Emmaus Medical
11.1.1 Emmaus Medical Company Information
11.1.2 Emmaus Medical Sickle Cell Anemia Therapeutics Product Offered
11.1.3 Emmaus Medical Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Emmaus Medical Main Business Overview
11.1.5 Emmaus Medical Latest Developments
11.2 Addmedica
11.2.1 Addmedica Company Information
11.2.2 Addmedica Sickle Cell Anemia Therapeutics Product Offered
11.2.3 Addmedica Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Addmedica Main Business Overview
11.2.5 Addmedica Latest Developments
11.3 Gamida Cell
11.3.1 Gamida Cell Company Information
11.3.2 Gamida Cell Sickle Cell Anemia Therapeutics Product Offered
11.3.3 Gamida Cell Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Gamida Cell Main Business Overview
11.3.5 Gamida Cell Latest Developments
11.4 GlycoMimetics
11.4.1 GlycoMimetics Company Information
11.4.2 GlycoMimetics Sickle Cell Anemia Therapeutics Product Offered
11.4.3 GlycoMimetics Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 GlycoMimetics Main Business Overview
11.4.5 GlycoMimetics Latest Developments
11.5 Pfizer
11.5.1 Pfizer Company Information
11.5.2 Pfizer Sickle Cell Anemia Therapeutics Product Offered
11.5.3 Pfizer Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Pfizer Main Business Overview
11.5.5 Pfizer Latest Developments
11.6 Novartis
11.6.1 Novartis Company Information
11.6.2 Novartis Sickle Cell Anemia Therapeutics Product Offered
11.6.3 Novartis Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Novartis Main Business Overview
11.6.5 Novartis Latest Developments
11.7 Global Blood Therapeutics
11.7.1 Global Blood Therapeutics Company Information
11.7.2 Global Blood Therapeutics Sickle Cell Anemia Therapeutics Product Offered
11.7.3 Global Blood Therapeutics Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Global Blood Therapeutics Main Business Overview
11.7.5 Global Blood Therapeutics Latest Developments
11.8 Micelle BioPharma
11.8.1 Micelle BioPharma Company Information
11.8.2 Micelle BioPharma Sickle Cell Anemia Therapeutics Product Offered
11.8.3 Micelle BioPharma Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Micelle BioPharma Main Business Overview
11.8.5 Micelle BioPharma Latest Developments
11.9 Bluebird Bio
11.9.1 Bluebird Bio Company Information
11.9.2 Bluebird Bio Sickle Cell Anemia Therapeutics Product Offered
11.9.3 Bluebird Bio Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Bluebird Bio Main Business Overview
11.9.5 Bluebird Bio Latest Developments
11.10 Prolong Pharmaceuticals
11.10.1 Prolong Pharmaceuticals Company Information
11.10.2 Prolong Pharmaceuticals Sickle Cell Anemia Therapeutics Product Offered
11.10.3 Prolong Pharmaceuticals Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Prolong Pharmaceuticals Main Business Overview
11.10.5 Prolong Pharmaceuticals Latest Developments
11.11 Modus Therapeutics
11.11.1 Modus Therapeutics Company Information
11.11.2 Modus Therapeutics Sickle Cell Anemia Therapeutics Product Offered
11.11.3 Modus Therapeutics Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Modus Therapeutics Main Business Overview
11.11.5 Modus Therapeutics Latest Developments
11.12 Sangamo Biosciences
11.12.1 Sangamo Biosciences Company Information
11.12.2 Sangamo Biosciences Sickle Cell Anemia Therapeutics Product Offered
11.12.3 Sangamo Biosciences Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Sangamo Biosciences Main Business Overview
11.12.5 Sangamo Biosciences Latest Developments
11.13 Bioverativ
11.13.1 Bioverativ Company Information
11.13.2 Bioverativ Sickle Cell Anemia Therapeutics Product Offered
11.13.3 Bioverativ Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Bioverativ Main Business Overview
11.13.5 Bioverativ Latest Developments
11.14 Imara
11.14.1 Imara Company Information
11.14.2 Imara Sickle Cell Anemia Therapeutics Product Offered
11.14.3 Imara Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Imara Main Business Overview
11.14.5 Imara Latest Developments
11.15 Ironwood Pharmaceuticals
11.15.1 Ironwood Pharmaceuticals Company Information
11.15.2 Ironwood Pharmaceuticals Sickle Cell Anemia Therapeutics Product Offered
11.15.3 Ironwood Pharmaceuticals Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Ironwood Pharmaceuticals Main Business Overview
11.15.5 Ironwood Pharmaceuticals Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Sickle Cell AnemiaTherapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Sickle Cell AnemiaTherapeutics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of BloodTransfusion
Table 4. Major Players of Pharmacotherapy
Table 5. Major Players of Bone MarrowTransplant
Table 6. Sickle Cell AnemiaTherapeutics Market Size CAGR byType (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Sickle Cell AnemiaTherapeutics Market Size byType (2020-2025) & ($ millions)
Table 8. Global Sickle Cell AnemiaTherapeutics Market Size Market Share byType (2020-2025)
Table 9. Sickle Cell AnemiaTherapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Sickle Cell AnemiaTherapeutics Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Sickle Cell AnemiaTherapeutics Market Size Market Share by Application (2020-2025)
Table 12. Global Sickle Cell AnemiaTherapeutics Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Sickle Cell AnemiaTherapeutics Revenue Market Share by Player (2020-2025)
Table 14. Sickle Cell AnemiaTherapeutics Key Players Head office and Products Offered
Table 15. Sickle Cell AnemiaTherapeutics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Sickle Cell AnemiaTherapeutics Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Sickle Cell AnemiaTherapeutics Market Size Market Share by Region (2020-2025)
Table 20. Global Sickle Cell AnemiaTherapeutics Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Sickle Cell AnemiaTherapeutics Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Sickle Cell AnemiaTherapeutics Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Sickle Cell AnemiaTherapeutics Market Size Market Share by Country (2020-2025)
Table 24. Americas Sickle Cell AnemiaTherapeutics Market Size byType (2020-2025) & ($ millions)
Table 25. Americas Sickle Cell AnemiaTherapeutics Market Size Market Share byType (2020-2025)
Table 26. Americas Sickle Cell AnemiaTherapeutics Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Sickle Cell AnemiaTherapeutics Market Size Market Share by Application (2020-2025)
Table 28. APAC Sickle Cell AnemiaTherapeutics Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Sickle Cell AnemiaTherapeutics Market Size Market Share by Region (2020-2025)
Table 30. APAC Sickle Cell AnemiaTherapeutics Market Size byType (2020-2025) & ($ millions)
Table 31. APAC Sickle Cell AnemiaTherapeutics Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Sickle Cell AnemiaTherapeutics Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Sickle Cell AnemiaTherapeutics Market Size Market Share by Country (2020-2025)
Table 34. Europe Sickle Cell AnemiaTherapeutics Market Size byType (2020-2025) & ($ millions)
Table 35. Europe Sickle Cell AnemiaTherapeutics Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Sickle Cell AnemiaTherapeutics Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Sickle Cell AnemiaTherapeutics Market Size byType (2020-2025) & ($ millions)
Table 38. Middle East & Africa Sickle Cell AnemiaTherapeutics Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Sickle Cell AnemiaTherapeutics
Table 40. Key Market Challenges & Risks of Sickle Cell AnemiaTherapeutics
Table 41. Key IndustryTrends of Sickle Cell AnemiaTherapeutics
Table 42. Global Sickle Cell AnemiaTherapeutics Market SizeForecast by Region (2026-2031) & ($ millions)
Table 43. Global Sickle Cell AnemiaTherapeutics Market Size Market ShareForecast by Region (2026-2031)
Table 44. Global Sickle Cell AnemiaTherapeutics Market SizeForecast byType (2026-2031) & ($ millions)
Table 45. Global Sickle Cell AnemiaTherapeutics Market SizeForecast by Application (2026-2031) & ($ millions)
Table 46. Emmaus Medical Details, CompanyType, Sickle Cell AnemiaTherapeutics Area Served and Its Competitors
Table 47. Emmaus Medical Sickle Cell AnemiaTherapeutics Product Offered
Table 48. Emmaus Medical Sickle Cell AnemiaTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Emmaus Medical Main Business
Table 50. Emmaus Medical Latest Developments
Table 51. Addmedica Details, CompanyType, Sickle Cell AnemiaTherapeutics Area Served and Its Competitors
Table 52. Addmedica Sickle Cell AnemiaTherapeutics Product Offered
Table 53. Addmedica Sickle Cell AnemiaTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Addmedica Main Business
Table 55. Addmedica Latest Developments
Table 56. Gamida Cell Details, CompanyType, Sickle Cell AnemiaTherapeutics Area Served and Its Competitors
Table 57. Gamida Cell Sickle Cell AnemiaTherapeutics Product Offered
Table 58. Gamida Cell Sickle Cell AnemiaTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Gamida Cell Main Business
Table 60. Gamida Cell Latest Developments
Table 61. GlycoMimetics Details, CompanyType, Sickle Cell AnemiaTherapeutics Area Served and Its Competitors
Table 62. GlycoMimetics Sickle Cell AnemiaTherapeutics Product Offered
Table 63. GlycoMimetics Sickle Cell AnemiaTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. GlycoMimetics Main Business
Table 65. GlycoMimetics Latest Developments
Table 66. Pfizer Details, CompanyType, Sickle Cell AnemiaTherapeutics Area Served and Its Competitors
Table 67. Pfizer Sickle Cell AnemiaTherapeutics Product Offered
Table 68. Pfizer Sickle Cell AnemiaTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. Pfizer Main Business
Table 70. Pfizer Latest Developments
Table 71. Novartis Details, CompanyType, Sickle Cell AnemiaTherapeutics Area Served and Its Competitors
Table 72. Novartis Sickle Cell AnemiaTherapeutics Product Offered
Table 73. Novartis Sickle Cell AnemiaTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Novartis Main Business
Table 75. Novartis Latest Developments
Table 76. Global BloodTherapeutics Details, CompanyType, Sickle Cell AnemiaTherapeutics Area Served and Its Competitors
Table 77. Global BloodTherapeutics Sickle Cell AnemiaTherapeutics Product Offered
Table 78. Global BloodTherapeutics Sickle Cell AnemiaTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. Global BloodTherapeutics Main Business
Table 80. Global BloodTherapeutics Latest Developments
Table 81. Micelle BioPharma Details, CompanyType, Sickle Cell AnemiaTherapeutics Area Served and Its Competitors
Table 82. Micelle BioPharma Sickle Cell AnemiaTherapeutics Product Offered
Table 83. Micelle BioPharma Sickle Cell AnemiaTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. Micelle BioPharma Main Business
Table 85. Micelle BioPharma Latest Developments
Table 86. Bluebird Bio Details, CompanyType, Sickle Cell AnemiaTherapeutics Area Served and Its Competitors
Table 87. Bluebird Bio Sickle Cell AnemiaTherapeutics Product Offered
Table 88. Bluebird Bio Sickle Cell AnemiaTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. Bluebird Bio Main Business
Table 90. Bluebird Bio Latest Developments
Table 91. Prolong Pharmaceuticals Details, CompanyType, Sickle Cell AnemiaTherapeutics Area Served and Its Competitors
Table 92. Prolong Pharmaceuticals Sickle Cell AnemiaTherapeutics Product Offered
Table 93. Prolong Pharmaceuticals Sickle Cell AnemiaTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 94. Prolong Pharmaceuticals Main Business
Table 95. Prolong Pharmaceuticals Latest Developments
Table 96. ModusTherapeutics Details, CompanyType, Sickle Cell AnemiaTherapeutics Area Served and Its Competitors
Table 97. ModusTherapeutics Sickle Cell AnemiaTherapeutics Product Offered
Table 98. ModusTherapeutics Sickle Cell AnemiaTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 99. ModusTherapeutics Main Business
Table 100. ModusTherapeutics Latest Developments
Table 101. Sangamo Biosciences Details, CompanyType, Sickle Cell AnemiaTherapeutics Area Served and Its Competitors
Table 102. Sangamo Biosciences Sickle Cell AnemiaTherapeutics Product Offered
Table 103. Sangamo Biosciences Sickle Cell AnemiaTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 104. Sangamo Biosciences Main Business
Table 105. Sangamo Biosciences Latest Developments
Table 106. Bioverativ Details, CompanyType, Sickle Cell AnemiaTherapeutics Area Served and Its Competitors
Table 107. Bioverativ Sickle Cell AnemiaTherapeutics Product Offered
Table 108. Bioverativ Sickle Cell AnemiaTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 109. Bioverativ Main Business
Table 110. Bioverativ Latest Developments
Table 111. Imara Details, CompanyType, Sickle Cell AnemiaTherapeutics Area Served and Its Competitors
Table 112. Imara Sickle Cell AnemiaTherapeutics Product Offered
Table 113. Imara Sickle Cell AnemiaTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 114. Imara Main Business
Table 115. Imara Latest Developments
Table 116. Ironwood Pharmaceuticals Details, CompanyType, Sickle Cell AnemiaTherapeutics Area Served and Its Competitors
Table 117. Ironwood Pharmaceuticals Sickle Cell AnemiaTherapeutics Product Offered
Table 118. Ironwood Pharmaceuticals Sickle Cell AnemiaTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 119. Ironwood Pharmaceuticals Main Business
Table 120. Ironwood Pharmaceuticals Latest Developments
LIST OFFIGURES
Figure 1. Sickle Cell AnemiaTherapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Sickle Cell AnemiaTherapeutics Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Sickle Cell AnemiaTherapeutics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Sickle Cell AnemiaTherapeutics Sales Market Share by Country/Region (2024)
Figure 8. Sickle Cell AnemiaTherapeutics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Sickle Cell AnemiaTherapeutics Market Size Market Share byType in 2024
Figure 10. Sickle Cell AnemiaTherapeutics in Child
Figure 11. Global Sickle Cell AnemiaTherapeutics Market: Child (2020-2025) & ($ millions)
Figure 12. Sickle Cell AnemiaTherapeutics in Adult
Figure 13. Global Sickle Cell AnemiaTherapeutics Market: Adult (2020-2025) & ($ millions)
Figure 14. Global Sickle Cell AnemiaTherapeutics Market Size Market Share by Application in 2024
Figure 15. Global Sickle Cell AnemiaTherapeutics Revenue Market Share by Player in 2024
Figure 16. Global Sickle Cell AnemiaTherapeutics Market Size Market Share by Region (2020-2025)
Figure 17. Americas Sickle Cell AnemiaTherapeutics Market Size 2020-2025 ($ millions)
Figure 18. APAC Sickle Cell AnemiaTherapeutics Market Size 2020-2025 ($ millions)
Figure 19. Europe Sickle Cell AnemiaTherapeutics Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa Sickle Cell AnemiaTherapeutics Market Size 2020-2025 ($ millions)
Figure 21. Americas Sickle Cell AnemiaTherapeutics Value Market Share by Country in 2024
Figure 22. United States Sickle Cell AnemiaTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada Sickle Cell AnemiaTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico Sickle Cell AnemiaTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil Sickle Cell AnemiaTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC Sickle Cell AnemiaTherapeutics Market Size Market Share by Region in 2024
Figure 27. APAC Sickle Cell AnemiaTherapeutics Market Size Market Share byType (2020-2025)
Figure 28. APAC Sickle Cell AnemiaTherapeutics Market Size Market Share by Application (2020-2025)
Figure 29. China Sickle Cell AnemiaTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan Sickle Cell AnemiaTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea Sickle Cell AnemiaTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia Sickle Cell AnemiaTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 33. India Sickle Cell AnemiaTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia Sickle Cell AnemiaTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe Sickle Cell AnemiaTherapeutics Market Size Market Share by Country in 2024
Figure 36. Europe Sickle Cell AnemiaTherapeutics Market Size Market Share byType (2020-2025)
Figure 37. Europe Sickle Cell AnemiaTherapeutics Market Size Market Share by Application (2020-2025)
Figure 38. Germany Sickle Cell AnemiaTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 39.France Sickle Cell AnemiaTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 40. UK Sickle Cell AnemiaTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy Sickle Cell AnemiaTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia Sickle Cell AnemiaTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa Sickle Cell AnemiaTherapeutics Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa Sickle Cell AnemiaTherapeutics Market Size Market Share byType (2020-2025)
Figure 45. Middle East & Africa Sickle Cell AnemiaTherapeutics Market Size Market Share by Application (2020-2025)
Figure 46. Egypt Sickle Cell AnemiaTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa Sickle Cell AnemiaTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel Sickle Cell AnemiaTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 49.Turkey Sickle Cell AnemiaTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries Sickle Cell AnemiaTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas Sickle Cell AnemiaTherapeutics Market Size 2026-2031 ($ millions)
Figure 52. APAC Sickle Cell AnemiaTherapeutics Market Size 2026-2031 ($ millions)
Figure 53. Europe Sickle Cell AnemiaTherapeutics Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa Sickle Cell AnemiaTherapeutics Market Size 2026-2031 ($ millions)
Figure 55. United States Sickle Cell AnemiaTherapeutics Market Size 2026-2031 ($ millions)
Figure 56. Canada Sickle Cell AnemiaTherapeutics Market Size 2026-2031 ($ millions)
Figure 57. Mexico Sickle Cell AnemiaTherapeutics Market Size 2026-2031 ($ millions)
Figure 58. Brazil Sickle Cell AnemiaTherapeutics Market Size 2026-2031 ($ millions)
Figure 59. China Sickle Cell AnemiaTherapeutics Market Size 2026-2031 ($ millions)
Figure 60. Japan Sickle Cell AnemiaTherapeutics Market Size 2026-2031 ($ millions)
Figure 61. Korea Sickle Cell AnemiaTherapeutics Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia Sickle Cell AnemiaTherapeutics Market Size 2026-2031 ($ millions)
Figure 63. India Sickle Cell AnemiaTherapeutics Market Size 2026-2031 ($ millions)
Figure 64. Australia Sickle Cell AnemiaTherapeutics Market Size 2026-2031 ($ millions)
Figure 65. Germany Sickle Cell AnemiaTherapeutics Market Size 2026-2031 ($ millions)
Figure 66.France Sickle Cell AnemiaTherapeutics Market Size 2026-2031 ($ millions)
Figure 67. UK Sickle Cell AnemiaTherapeutics Market Size 2026-2031 ($ millions)
Figure 68. Italy Sickle Cell AnemiaTherapeutics Market Size 2026-2031 ($ millions)
Figure 69. Russia Sickle Cell AnemiaTherapeutics Market Size 2026-2031 ($ millions)
Figure 70. Egypt Sickle Cell AnemiaTherapeutics Market Size 2026-2031 ($ millions)
Figure 71. South Africa Sickle Cell AnemiaTherapeutics Market Size 2026-2031 ($ millions)
Figure 72. Israel Sickle Cell AnemiaTherapeutics Market Size 2026-2031 ($ millions)
Figure 73.Turkey Sickle Cell AnemiaTherapeutics Market Size 2026-2031 ($ millions)
Figure 74. Global Sickle Cell AnemiaTherapeutics Market Size Market ShareForecast byType (2026-2031)
Figure 75. Global Sickle Cell AnemiaTherapeutics Market Size Market ShareForecast by Application (2026-2031)
Figure 76. GCC Countries Sickle Cell AnemiaTherapeutics Market Size 2026-2031 ($ millions)
